Umang Swami

3.1k citations

173 papers · 1.6k indexed · h-index 21

Health Informatics top 2%
Oncology top 5%
- Cancer Immunotherapy and Biomarkers 39
- PARP inhibition in cancer therapy 18
- CAR-T cell therapy research 17
Pulmonary and Respiratory Medicine top 5%
- Prostate Cancer Treatment and Research 78
Cancer Research top 10%
- Cancer, Lipids, and Metabolism 27
- Cancer Genomics and Diagnostics 17
Immunology
Radiology, Nuclear Medicine and Imaging
- Radiopharmaceutical Chemistry and Applications 28
Surgery
- Bladder and Urothelial Cancer Treatments 23

Co-authors: Neeraj Agarwal Sanjay Goel Taylor Ryan McFarland Roberto Nussenzveig Mohammed Milhem Yousef Zakharia Sridhar Mani Nicolas Sayegh
Cited by: Health Informatics Oncology Pulmonary and Respiratory Medicine
Journals: Circulation (1 paper)Journal of Clinical Oncology (52 papers)SHILAP Revista de lepidopterología (1 paper)
Partner nations: United States United Kingdom Spain

In The Last Decade

Umang Swami

147 papers receiving 1.6k citations

Peers

Countries citing papers authored by Umang Swami

Since Specialization

Citations

This map shows the geographic impact of Umang Swami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umang Swami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umang Swami more than expected).

Fields of papers citing papers by Umang Swami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umang Swami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umang Swami. The network helps show where Umang Swami may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Umang Swami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Umang Swami Line = papers co-authored together Umang Swami links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Association of Homologous Recombination Repair Alterations with Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer Clinical Cancer Research ·Chadi Hage Chehade,Ryon P. Graf,Zeynep İrem Özay,Georges Gebrael,Nicolas Sayegh,Gerald Li,Benjamin L. Maughan,Emmanuel S. Antonarakis,Rana R. McKay,Neeraj Agarwal,Umang Swami	2025	0
2	Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial BMC Cancer ·Adriana M. Coletta,Lea Haverbeck Simon,Kelsey E. Maslana,Sarah Taylor,Kish Larson,Pamela A. Hansen,Vinay Mathew Thomas,Cornelia M. Ulrich,Manish Kohli,Jonathan Chipman,Umang Swami,Sumati Gupta,Benjamin L. Maughan,Neeraj Agarwal	2024	1
3	PD09-05 DIFFERENCES IN GENOMIC, TRANSCRIPTOMIC AND IMMUNE LANDSCAPE OF PROSTATE CANCER (PCA) BASED ON SITE OF METASTASIS (METS) The Journal of Urology ·Dhruv Puri,Umang Swami,Georges Gebrael,Shayan Nazari,Andrew Elliott,Chadi Nabhan,Rana R. McKay,Emmanuel S. Antonarakis,Aditya Bagrodia,Neeraj Agarwal	2024	1
4	Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials JAMA Network Open ·Sanjay Goel,Abdissa Negassa,Mohammad H. Ghalib,Imran Chaudhary,Kavita Desai,Umang Shah,Umang Swami,Bruce Cohen,Radhashree Maitra,Sridhar Mani	2024	0
5	1966MO EV-302: Exploratory analysis of nectin-4 expression and response to 1L enfortumab vedotin (EV) + pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC) Annals of Oncology ·Thomas Powles,Michiel S. van der Heijden,Shilpa Gupta,Begoña P. Valderrama,M.D. Galsky,J. Bedke,Eiji Kikuchi,Jean Hoffman‐Censits,J.P. Maroto Rey,Christof Vulsteke,Gopa Iyer,Umang Swami,Sang Joon Shin,Alejo Rodríguez‐Vida,Michał Woźniak,Blanca Homet Moreno,Jie Lu,Changjun Yu,Leah J. Hogdal,Yohann Loriot	2024	13
6	Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI JCO Precision Oncology ·Vinay Mathew Thomas,Beverly Chigarira,Georges Gebrael,Nicolas Sayegh,Nishita Tripathi,Roberto Nussenzveig,Yeonjung Jo,Emre Dal,Gliceida Galarza Fortuna,Haoran Li,Kamal Kant Sahu,Ayana Srivastava,Benjamin L. Maughan,Neeraj Agarwal,Umang Swami	2024	1
7	Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma Diagnostics ·Emre Dal,Ayana Srivastava,Beverly Chigarira,Chadi Hage Chehade,Vinay Matthew Thomas,Gliceida Galarza Fortuna,Diya Garg,Richard Ji,Georges Gebrael,Neeraj Agarwal,Umang Swami,Haoran Li	2024	1
8	Phase I/II trial of LAVA-1207, a novel bispecific gamma-delta T-cell engager alone, or with low dose IL-2 or pembrolizumab, in metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology ·Niven Mehra,Jens Voortman,David R. Wise,Emiliano Calvo,Josep M. Piulats,Enrique González‐Billalabeitia,Ignacio Ortego,Umang Swami,Joel Picus,Meghan Karlik,Teeru Bihani,Jurjen M. Ruben,Sonia Maciá,Hans van Vliet,Marya Chaney,Debbie Robbrecht	2024	4
9	Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor Cancer ·Georges Gebrael,Yeonjung Jo,Vinay Mathew Thomas,Haoran Li,Nicolas Sayegh,Nishita Tripathi,Ayana Srivastava,Blake Nordblad,Emre Dal,Arshit Narang,James Brundage,Patrick Campbell,Gliceida Galarza Fortuna,Chadi Hage Chehade,Benjamin L. Maughan,Neeraj Agarwal,Umang Swami	2024	2
10	Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting The Prostate ·Georges Gebrael,Chadi Hage Chehade,Nicolas Sayegh,Nishita Tripathi,Beverly Chigarira,Divyam Goel,Blake Nordblad,Taylor Ryan McFarland,Arshit Narang,Ayana Srivastava,Clara Tandar,Emre Dal,Yeonjung Jo,Gliceida Galarza Fortuna,Vinay Mathew Thomas,Kamal Kant Sahu,Haoran Li,Benjamin L. Maughan,Umang Swami,Neeraj Agarwal	2024	1
11	A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome Frontiers in Immunology ·John Marsiglio,Jordan P. McPherson,Magdalena Kovacsovics-Bankowski,Joanne Jeter,Christos Vaklavas,Umang Swami,Douglas Grossmann,Alyssa Erickson‐Wayman,Heloisa P. Soares,Katie Kerrigan,Berit Gibson,Jennifer A. Doherty,John Hyngstrom,Sheetal Hardikar,Siwen Hu‐Lieskovan	2023	16
12	Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas Cancers ·Haoran Li,Kamal Kant Sahu,Shruti Adidam Kumar,Nishita Tripathi,Nicolas Sayegh,Blake Nordblad,Beverly Chigarira,Sumati Gupta,Benjamin L. Maughan,Neeraj Agarwal,Umang Swami	2023	1
13	Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer JAMA Network Open ·Nicolas Sayegh,Umang Swami,Yeonjung Jo,Georges Gebrael,Benjamin Haaland,Shilpa Gupta,Melissa Plets,Maha Hussain,David I. Quinn,Primo N. Lara,Ian M. Thompson,Neeraj Agarwal	2023	5
14	Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare Data Clinical Genitourinary Cancer ·Umang Swami,Himani Aggarwal,Mo Zhou,Shan Jiang,Jeri Kim,Weiyan Li,François Laliberté,Bruno Émond,Neeraj Agarwal	2023	6
15	Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden Journal for ImmunoTherapy of Cancer ·Vaia Florou,Charalampos S. Floudas,Asaf Maoz,Abdul Rafeh Naqash,Carter Norton,Aik Choon Tan,Ethan Sokol,Garrett M. Frampton,Heloisa P. Soares,Sonam Puri,Umang Swami,Breelyn A. Wilky,Peter J. Hosein,Jonathan C. Trent,Gilberto Lopes,Wungki Park,Ignacio Garrido‐Laguna	2023	9
16	External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer Molecular Cancer Therapeutics ·Umang Swami,Nicolas Sayegh,Yeonjung Jo,Benjamin Haaland,Taylor Ryan McFarland,Roberto Nussenzveig,Divyam Goel,Deepika Sirohi,Andrew W. Hahn,Benjamin L. Maughan,Amir Goldkorn,Neeraj Agarwal	2022	5
17	A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers Heliyon ·Haoran Li,Kamal Kant Sahu,Shruti Adidam Kumar,Blake Nordblad,Nicolas Sayegh,Nishita Tripathi,Vinay Mathew Thomas,Sumati Gupta,Benjamin L. Maughan,Neeraj Agarwal,Umang Swami	2022	2
18	Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting Biomedicines ·Taylor Ryan McFarland,Vinay Mathew Thomas,Roberto Nussenzveig,Georges Gebrael,Nicolas Sayegh,Nishita Tripathi,Kamal Kant Sahu,Divyam Goel,Benjamin L. Maughan,Deepika Sirohi,Neeraj Agarwal,Umang Swami	2022	2
19	SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer Clinical Cancer Research ·Umang Swami,Ryon P. Graf,Roberto Nussenzveig,Virginia Fisher,Hanna Tukachinsky,Alexa B. Schrock,Gerald Li,Jeffrey S. Ross,Nicolas Sayegh,Nishita Tripathi,Vinay Mathew Thomas,Geoffrey R. Oxnard,Emmanuel S. Antonarakis,Neeraj Agarwal	2022	40
20	Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform The Oncologist ·Edwin Lin,Andrew W. Hahn,Roberto Nussenzveig,Sergiusz Wesołowski,Nicolas Sayegh,Benjamin L. Maughan,Taylor Ryan McFarland,Nityam Rathi,Deepika Sirohi,Guru Sonpavde,Umang Swami,Manish Kohli,Thereasa A. Rich,Oliver Sartor,Mark Yandell,Neeraj Agarwal	2021	11

About Umang Swami

Umang Swami is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 173 papers that have together received 1.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (78 papers), Cancer Immunotherapy and Biomarkers (39 papers), Radiopharmaceutical Chemistry and Applications (28 papers), Cancer, Lipids, and Metabolism (27 papers), Bladder and Urothelial Cancer Treatments (23 papers), PARP inhibition in cancer therapy (18 papers), Cancer Genomics and Diagnostics (17 papers) and CAR-T cell therapy research (17 papers). The work is most often cited by research in Health Informatics (51 citations), Oncology (727 citations) and Pulmonary and Respiratory Medicine (634 citations). Umang Swami has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Neeraj Agarwal, Sanjay Goel, Taylor Ryan McFarland, Roberto Nussenzveig, Mohammed Milhem, Yousef Zakharia, Sridhar Mani, Nicolas Sayegh, Benjamin L. Maughan and Nishita Tripathi. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact